Dr. Reddy’s acquires trademark rights of breast cancer drug PRIMCYV from Pfizer
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
Dr. Reddy’s will manufacture the Active Pharmaceutical Ingredient and finished drug at its facilities approved by USFDA
This will give either party customers access enzyme expertise and assets, resulting in cost-effective, green processing for API manufacturing.
Exceeding the target of 1.50 lakh Ayushman Bharat - Health & Wellness Centres (AB-HWC) by 31 December, 2022, more than 1.54 lakh Sub Health Centres and Primary Health Centres have been transformed as AB-HWCs
The implementing agency of PMBJP has invited online applications for opening of new Jan Aushadhi Kendras in 651 districts of different States/UTs
Brexpiprazole is an atypical antipsychotic indicated for use as an adjunctive therapy to antidepressants for the treatment of major depressive disorder (MDD) in adults
Swiftmelt 1515-I meets performance requirements and secures skin attachment
Palbociclib has a unique mechanism of action which helps in delaying disease progression when co-administered with hormonal therapies
Launch of Apollo Genomics Institutes would provide genetic counselling, tests, treatment and care for genetic disorders
The objective of this system is to shift the focus of measuring performance of hospitals from volume of services provided to value of healthcare services
Subscribe To Our Newsletter & Stay Updated